Annual Operating Profit
-$15.97 M
+$65.90 K+0.41%
December 31, 2022
Summary
- As of February 10, 2025, DFFN annual operating income is -$15.97 million, with the most recent change of +$65.90 thousand (+0.41%) on December 31, 2022.
- During the last 3 years, DFFN annual operating profit has fallen by -$4.42 million (-38.27%).
Performance
DFFN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Profit
-$2.29 M
+$1.97 M+46.26%
June 30, 2023
Summary
- As of February 10, 2025, DFFN quarterly operating income is -$2.29 million, with the most recent change of +$1.97 million (+46.26%) on June 30, 2023.
- Over the past year, DFFN quarterly operating profit has increased by +$1.95 million (+46.00%).
Performance
DFFN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Operating Profit
-$13.73 M
+$1.95 M+12.45%
June 30, 2023
Summary
- As of February 10, 2025, DFFN TTM operating income is -$13.73 million, with the most recent change of +$1.95 million (+12.45%) on June 30, 2023.
- Over the past year, DFFN TTM operating profit has increased by +$2.59 million (+15.87%).
Performance
DFFN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
DFFN Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.4% | +46.0% | +15.9% |
| 3 y3 years | -38.3% | +37.3% | -8.8% |
| 5 y5 years | -40.7% | +25.5% | -18.9% |
DFFN Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +0.4% | at high | +98.7% | at high | +18.9% |
| 5 y | 5-year | +38.3% | +0.4% | at high | +130.0% | +18.9% | +30.2% |
| alltime | all time | -2705.6% | +15.0% | -381.8% | +171.4% | -8210.3% | +34.0% |
Diffusion Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$2.29 M(-46.3%) | -$13.73 M(-12.5%) |
| Mar 2023 | - | -$4.27 M(+0.4%) | -$15.68 M(-1.8%) |
| Dec 2022 | -$15.97 M(-0.4%) | -$4.25 M(+45.4%) | -$15.97 M(+5.2%) |
| Sep 2022 | - | -$2.92 M(-31.2%) | -$15.19 M(-6.9%) |
| Jun 2022 | - | -$4.25 M(-6.8%) | -$16.32 M(+2.6%) |
| Mar 2022 | - | -$4.55 M(+31.4%) | -$15.91 M(-0.8%) |
| Dec 2021 | -$16.04 M(+0.4%) | -$3.47 M(-14.5%) | -$16.04 M(-3.7%) |
| Sep 2021 | - | -$4.05 M(+5.8%) | -$16.66 M(-6.8%) |
| Jun 2021 | - | -$3.83 M(-18.2%) | -$17.88 M(+1.0%) |
| Mar 2021 | - | -$4.68 M(+14.6%) | -$17.70 M(+10.8%) |
| Dec 2020 | -$15.97 M(+38.3%) | -$4.09 M(-22.5%) | -$15.97 M(+7.6%) |
| Sep 2020 | - | -$5.27 M(+44.2%) | -$14.85 M(+17.6%) |
| Jun 2020 | - | -$3.66 M(+23.8%) | -$12.63 M(+9.0%) |
| Mar 2020 | - | -$2.96 M(-0.1%) | -$11.59 M(+0.3%) |
| Dec 2019 | -$11.55 M(-4.0%) | -$2.96 M(-3.0%) | -$11.55 M(+1.3%) |
| Sep 2019 | - | -$3.05 M(+16.4%) | -$11.41 M(+2.4%) |
| Jun 2019 | - | -$2.62 M(-10.2%) | -$11.14 M(-3.9%) |
| Mar 2019 | - | -$2.92 M(+3.7%) | -$11.60 M(-3.6%) |
| Dec 2018 | -$12.03 M(+6.0%) | -$2.81 M(+1.0%) | -$12.03 M(+3.1%) |
| Sep 2018 | - | -$2.79 M(-9.5%) | -$11.67 M(-4.6%) |
| Jun 2018 | - | -$3.08 M(-8.1%) | -$12.23 M(+0.8%) |
| Mar 2018 | - | -$3.35 M(+36.6%) | -$12.13 M(+6.9%) |
| Dec 2017 | -$11.35 M(-38.2%) | -$2.45 M(-26.7%) | -$11.35 M(-0.8%) |
| Sep 2017 | - | -$3.35 M(+12.2%) | -$11.44 M(-17.7%) |
| Jun 2017 | - | -$2.98 M(+16.1%) | -$13.89 M(-5.6%) |
| Mar 2017 | - | -$2.57 M(+1.0%) | -$14.71 M(-19.9%) |
| Dec 2016 | -$18.37 M(+186.8%) | -$2.54 M(-56.2%) | -$18.36 M(-0.1%) |
| Sep 2016 | - | -$5.80 M(+52.6%) | -$18.39 M(+32.0%) |
| Jun 2016 | - | -$3.80 M(-38.9%) | -$13.94 M(+21.9%) |
| Mar 2016 | - | -$6.22 M(+142.2%) | -$11.44 M(+78.5%) |
| Dec 2015 | -$6.41 M(-19.4%) | -$2.57 M(+90.8%) | -$6.41 M(+25.7%) |
| Sep 2015 | - | -$1.35 M(+3.7%) | -$5.10 M(-29.8%) |
| Jun 2015 | - | -$1.30 M(+8.8%) | -$7.26 M(-6.5%) |
| Mar 2015 | - | -$1.19 M(-5.2%) | -$7.76 M(-2.3%) |
| Dec 2014 | -$7.94 M | -$1.26 M(-64.2%) | -$7.94 M(-33.0%) |
| Sep 2014 | - | -$3.51 M(+94.9%) | -$11.85 M(+26.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$1.80 M(+31.4%) | -$9.38 M(-18.2%) |
| Mar 2014 | - | -$1.37 M(-73.5%) | -$11.46 M(+5.5%) |
| Dec 2013 | -$10.86 M(+61.5%) | -$5.17 M(+400.6%) | -$10.86 M(+62.0%) |
| Sep 2013 | - | -$1.03 M(-73.4%) | -$6.70 M(-4.5%) |
| Jun 2013 | - | -$3.88 M(+399.9%) | -$7.02 M(+30.3%) |
| Mar 2013 | - | -$776.50 K(-23.3%) | -$5.39 M(-19.9%) |
| Dec 2012 | -$6.72 M(-43.1%) | -$1.01 M(-25.1%) | -$6.72 M(-30.3%) |
| Sep 2012 | - | -$1.35 M(-39.9%) | -$9.65 M(-22.4%) |
| Jun 2012 | - | -$2.25 M(+6.5%) | -$12.44 M(+1.6%) |
| Mar 2012 | - | -$2.11 M(-46.4%) | -$12.25 M(+3.7%) |
| Dec 2011 | -$11.81 M(+69.1%) | -$3.94 M(-4.8%) | -$11.81 M(+15.8%) |
| Sep 2011 | - | -$4.14 M(+101.3%) | -$10.20 M(+32.4%) |
| Jun 2011 | - | -$2.06 M(+22.8%) | -$7.70 M(+3.2%) |
| Mar 2011 | - | -$1.67 M(-28.1%) | -$7.47 M(+6.8%) |
| Dec 2010 | -$6.99 M(+137.0%) | -$2.33 M(+41.6%) | -$6.99 M(+17.9%) |
| Sep 2010 | - | -$1.64 M(-9.7%) | -$5.93 M(+22.2%) |
| Jun 2010 | - | -$1.82 M(+52.2%) | -$4.85 M(+40.3%) |
| Mar 2010 | - | -$1.20 M(-5.8%) | -$3.46 M(+30.8%) |
| Dec 2009 | -$2.95 M(+144.2%) | -$1.27 M(+123.5%) | -$2.64 M(+46.9%) |
| Sep 2009 | - | -$567.80 K(+33.4%) | -$1.80 M(+18.4%) |
| Jun 2009 | - | -$425.70 K(+11.8%) | -$1.52 M(+14.5%) |
| Mar 2009 | - | -$380.90 K(-10.3%) | -$1.33 M(+9.9%) |
| Dec 2008 | -$1.21 M(+2063.8%) | -$424.60 K(+47.3%) | -$1.21 M(-4007.1%) |
| Sep 2008 | - | -$288.20 K(+23.5%) | $30.90 K(-81.7%) |
| Jun 2008 | - | -$233.30 K(-10.7%) | $169.30 K(+125.4%) |
| Mar 2008 | - | -$261.20 K(-132.1%) | $75.10 K(-234.6%) |
| Dec 2007 | -$55.80 K(+33.2%) | $813.60 K(-643.1%) | -$55.80 K(-93.8%) |
| Sep 2007 | - | -$149.80 K(-54.3%) | -$900.50 K(+19.4%) |
| Jun 2007 | - | -$327.50 K(-16.5%) | -$754.30 K(+60.0%) |
| Mar 2007 | - | -$392.10 K(+1160.8%) | -$471.50 K(+468.1%) |
| Dec 2006 | -$41.90 K(-54.6%) | -$31.10 K(+763.9%) | -$83.00 K(+59.9%) |
| Sep 2006 | - | -$3600.00(-91.9%) | -$51.90 K(+7.5%) |
| Jun 2006 | - | -$44.70 K(+1141.7%) | -$48.30 K(+1241.7%) |
| Mar 2006 | - | -$3600.00 | -$3600.00 |
| Dec 2005 | -$92.20 K(-98.7%) | - | - |
| Dec 1999 | -$7.22 M(-1278.5%) | - | - |
| Dec 1998 | $613.00 K | - | - |
FAQ
- What is Diffusion Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals annual operating profit year-on-year change?
- What is Diffusion Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals quarterly operating profit year-on-year change?
- What is Diffusion Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals TTM operating profit year-on-year change?
What is Diffusion Pharmaceuticals annual operating income?
The current annual operating profit of DFFN is -$15.97 M
What is the all time high annual operating profit for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high annual operating income is $613.00 K
What is Diffusion Pharmaceuticals annual operating profit year-on-year change?
Over the past year, DFFN annual operating income has changed by +$65.90 K (+0.41%)
What is Diffusion Pharmaceuticals quarterly operating income?
The current quarterly operating profit of DFFN is -$2.29 M
What is the all time high quarterly operating profit for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high quarterly operating income is $813.60 K
What is Diffusion Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, DFFN quarterly operating income has changed by +$1.95 M (+46.00%)
What is Diffusion Pharmaceuticals TTM operating income?
The current TTM operating profit of DFFN is -$13.73 M
What is the all time high TTM operating profit for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high TTM operating income is $169.30 K
What is Diffusion Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, DFFN TTM operating income has changed by +$2.59 M (+15.87%)